Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Baxter

Showing results (651-660 of 668) with videos related to

Pageof 67
Sort By:
Neuro-Oncology|November 19, 2024
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group studyMatthias A Karajannis, Arzu Onar-Thomas, Tong Lin, et al.
Microbiology Resource Announcements|May 18, 2019
Complete Genome Sequences of Nine Mycobacteriophages from New Zealand, Beatrix, Carthage, Daegal, Dulcie, Fancypants, Fenn, Inca, Naira, and RobynC G Davies, J K Wojtus, C E R Gilligan, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 1999
Thrombin inhibitors based on [5,5] trans-fused indane lactamsM Pass, S Abu-Rabie, A Baxter, et al.
Oncotarget|November 21, 2017
Xenotransplantation of pediatric low grade gliomas confirms the enrichment of <i>BRAF</i> V600E mutation and preservation of <i>CDKN2A</i> deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytomaMari Kogiso, Lin Qi, Holly Lindsay, et al.
Cell Death & Disease|February 9, 2024
The small molecule raptinal can simultaneously induce apoptosis and inhibit PANX1 activityJascinta P Santavanond, Yu-Hsin Chiu, Rochelle Tixeira, et al.
British Journal of Cancer|February 21, 2024
CAnceR IN PreGnancy (CARING) - a retrospective study of cancer diagnosed during pregnancy in the United KingdomM A Baxter, M Denholm, S J Kingdon, et al.
Neuro-Oncology|December 19, 2024
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trialKarsten Nysom, Lindsay B Kilburn, Sarah E S Leary, et al.
Stem Cells Translational Medicine|February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesJames A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
European Heart Journal|December 15, 2021
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease, , E Sammons, et al.
Nature Medicine|March 12, 2024
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trialLindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford, et al.
Pageof 67

Showing results (651-660 of 668) with videos related to

Sort By:
Pageof 67
Neuro-Oncology|November 19, 2024
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group studyMatthias A Karajannis, Arzu Onar-Thomas, Tong Lin, et al.
Microbiology Resource Announcements|May 18, 2019
Complete Genome Sequences of Nine Mycobacteriophages from New Zealand, Beatrix, Carthage, Daegal, Dulcie, Fancypants, Fenn, Inca, Naira, and RobynC G Davies, J K Wojtus, C E R Gilligan, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 1999
Thrombin inhibitors based on [5,5] trans-fused indane lactamsM Pass, S Abu-Rabie, A Baxter, et al.
Oncotarget|November 21, 2017
Xenotransplantation of pediatric low grade gliomas confirms the enrichment of <i>BRAF</i> V600E mutation and preservation of <i>CDKN2A</i> deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytomaMari Kogiso, Lin Qi, Holly Lindsay, et al.
Cell Death & Disease|February 9, 2024
The small molecule raptinal can simultaneously induce apoptosis and inhibit PANX1 activityJascinta P Santavanond, Yu-Hsin Chiu, Rochelle Tixeira, et al.
British Journal of Cancer|February 21, 2024
CAnceR IN PreGnancy (CARING) - a retrospective study of cancer diagnosed during pregnancy in the United KingdomM A Baxter, M Denholm, S J Kingdon, et al.
Neuro-Oncology|December 19, 2024
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trialKarsten Nysom, Lindsay B Kilburn, Sarah E S Leary, et al.
Stem Cells Translational Medicine|February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesJames A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
European Heart Journal|December 15, 2021
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease, , E Sammons, et al.
Nature Medicine|March 12, 2024
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trialLindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford, et al.
Pageof 67